Biosint Omega3 (Fish Oil Concentrate)

Biosint Omega3 is a concentrated fish oil supplement containing EPA and DHA fatty acids that modulate inflammatory pathways through eicosanoid metabolism. These omega-3 fatty acids incorporate into cell membranes and promote production of anti-inflammatory resolvins and protectins.

Origin & History

Biosint Omega3 is a branded fish oil concentrate derived from wild-caught marine fatty fish, processed using a proprietary low-temperature refinement method that avoids high-heat molecular distillation. The process includes natural antioxidants like rosemary, vitamin C, and tocopherols to prevent rancidity, yielding a natural triglyceride form containing EPA (C20:5 n-3) and DHA (C22:6 n-3).

Historical & Cultural Context

No historical or traditional medicine context was found for Biosint Omega3 in the research. Use appears to stem from modern supplementation practices rather than ancient medicinal systems.

Health Benefits

• No clinical trials specifically on Biosint Omega3 were found in the research dossier
• General omega-3 mechanisms suggest potential anti-inflammatory effects through eicosanoid modulation and resolvin/protectin production (mechanism data only)
• May influence cell membrane function through incorporation of EPA and DHA fatty acids (theoretical based on biochemistry)
• Could modulate gene expression through PPAR and SREBP pathways (mechanistic evidence only)
• No specific health outcomes documented for this branded ingredient

How It Works

EPA and DHA in Biosint Omega3 incorporate into cell membrane phospholipids, displacing arachidonic acid and reducing pro-inflammatory eicosanoid production via COX and LOX pathways. These omega-3 fatty acids serve as precursors for specialized pro-resolving mediators including resolvins, protectins, and maresins. The altered membrane composition also affects membrane fluidity and receptor function in cardiovascular tissues.

Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on Biosint Omega3 were identified in the research dossier. The available evidence consists only of general omega-3 fatty acid mechanisms and standardization specifications.

Clinical Summary

No specific clinical trials have been conducted on Biosint Omega3 as a proprietary ingredient. The available evidence is based on general omega-3 fish oil research, which includes numerous randomized controlled trials on cardiovascular outcomes. Meta-analyses of omega-3 supplementation studies typically involve thousands of participants and show modest benefits for triglyceride reduction and cardiovascular risk markers. Without direct clinical data on this specific concentrate, efficacy claims must rely on established omega-3 research.

Nutritional Profile

Biosint Omega3 is a concentrated fish oil supplement standardized to deliver high levels of long-chain polyunsaturated fatty acids (LC-PUFAs), primarily EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). As a concentrate, typical formulations contain EPA at approximately 180–400 mg per gram of oil and DHA at approximately 120–300 mg per gram of oil, with total omega-3 content generally ranging from 60–85% of total fatty acids depending on concentration grade (e.g., 60%, 70%, or 85% ethyl ester or triglyceride forms). Remaining fatty acids include minor amounts of omega-6 (linoleic acid, arachidonic acid) and saturated fats (palmitic acid ~5–10%, stearic acid ~1–3%). Micronutrient content includes naturally occurring Vitamin D3 (trace levels, typically 1–4 IU per gram of oil) and Vitamin A (variable, often removed during refining). Vitamin E (tocopherols) is commonly added as an antioxidant stabilizer at approximately 0.1–0.5 mg/g to prevent lipid peroxidation. Cholesterol content is low post-concentration, typically 0.5–2 mg per gram. The product contains no carbohydrates, no dietary fiber, and negligible protein. Bioavailability note: triglyceride (re-esterified TG) forms demonstrate approximately 20–30% superior absorption compared to ethyl ester (EE) forms under fasted conditions; absorption is significantly enhanced when consumed with a high-fat meal. The 'Biosint' designation suggests a pharmaceutical-grade or semi-synthetic concentrate produced via molecular distillation, implying reduced heavy metal and PCB contamination relative to standard fish oils.

Preparation & Dosage

Typical dosage is 1g providing 350mg total omega-3 fatty acids (180mg EPA, 120mg DHA, 50mg other omega-3s) in softgel form. USP standards require ≥28% total omega-3 acids (≥13% EPA, ≥9% DHA) for similar concentrates. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, Vitamin C, Rosemary extract, Coenzyme Q10, Astaxanthin

Safety & Interactions

Fish oil supplements like Biosint Omega3 are generally well-tolerated but may cause gastrointestinal upset, fishy aftertaste, and increased bleeding risk at high doses. Omega-3 supplements can interact with anticoagulant medications like warfarin, potentially enhancing bleeding effects. Individuals with fish allergies should exercise caution, though refined fish oils typically have minimal allergenic proteins. Pregnant and nursing women should consult healthcare providers before use, as omega-3 needs vary during these periods.